Drug Discovery

Are the R&D pipelines of multinational drug companies drying up?

Current Voting

63%

25%

12%

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X